These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3571406)

  • 1. High-performance liquid chromatographic determination of nafimidone and its major metabolite nafimidone alcohol in human plasma and urine.
    Gunawan S; Treiman DM
    J Chromatogr; 1987 Mar; 414(2):389-98. PubMed ID: 3571406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of nafimidone [1-(2-naphthoylmethyl)imidazole], a new anticonvulsant agent, and a major metabolite in plasma by high-performance liquid chromatography.
    Graham DJ; Eadie J; Leadbetter BM; Metcalf R
    J Chromatogr; 1983 Jun; 275(1):211-6. PubMed ID: 6409915
    [No Abstract]   [Full Text] [Related]  

  • 3. The metabolism of nafimidone hydrochloride in the dog, primates and man.
    Rush WR; Alexander OF; Hall DJ; Dow RJ; Tokes L; Kurz L; Graham DJ
    Xenobiotica; 1990 Jan; 20(1):123-32. PubMed ID: 2109431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of nafimidone in patients with chronic intractable epilepsy.
    Treiman DM; Gunawan S
    Clin Pharmacokinet; 1987 Jun; 12(6):433-9. PubMed ID: 3608344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nafimidone, an imidazole anticonvulsant, and its metabolite as potent inhibitors of microsomal metabolism of phenytoin and carbamazepine.
    Kapetanovic IM; Kupferberg HJ
    Drug Metab Dispos; 1984; 12(5):560-4. PubMed ID: 6149905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a stability-indicating assay for nafimidone [1-(2-naphthoylmethyl)imidazole hydrochloride] by high-performance liquid chromatography.
    Taylor RB; Durham DG; Shivji AS; Reid R
    J Chromatogr; 1986 Feb; 353():51-9. PubMed ID: 3700525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of nafimidone in rats.
    Graham DJ; Hama KM; Smith SA; Kurz L; Chaplin MD; Hall DJ
    Drug Metab Dispos; 1987; 15(4):565-70. PubMed ID: 2888632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition and induction of hepatic drug metabolism in rats and mice by nafimidone and its major metabolite nafimidone alcohol.
    Rush WR; Smith SA; Mulvey JH; Graham DJ; Chaplin MD
    Drug Metab Dispos; 1987; 15(4):571-8. PubMed ID: 2888633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of (arylalkyl)imidazole anticonvulsants: comparison of the (fluorenylalkyl)imidazoles with nafimidone and denzimol.
    Robertson DW; Krushinski JH; Beedle EE; Leander JD; Wong DT; Rathbun RC
    J Med Chem; 1986 Sep; 29(9):1577-86. PubMed ID: 3746810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of carbamazepine and phenytoin metabolism by nafimidone, a new antiepileptic drug.
    Treiman DM; Ben-Menachem E
    Epilepsia; 1987; 28(6):699-705. PubMed ID: 3121287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of denzimol, a new anticonvulsant agent, and its main metabolite in biological material by gas chromatography and high-performance liquid chromatography.
    Bertin D; Cova A; Reschiotto C; Tajana A
    J Chromatogr; 1986 May; 378(1):147-54. PubMed ID: 3733967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the anticonvulsants, denzimol and nafimidone, with liver cytochrome P450 in the rat.
    Salmona M; Conti I; Testa R; Fracasso C; Caccia S
    J Pharm Pharmacol; 1988 Jan; 40(1):17-21. PubMed ID: 2896768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatographic determination of benzalkonium and naphazoline or tetrahydrozoline in nasal and ophthalmic solutions.
    Santoni G; Medica A; Gratteri P; Furlanetto S; Pinzauti S
    Farmaco; 1994 Nov; 40(11):751-4. PubMed ID: 7530451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-performance liquid chromatographic stability-indicating assay for naphazoline and tetrahydrozoline in ophthalmic preparations.
    Bauer J; Krogh S
    J Pharm Sci; 1983 Nov; 72(11):1347-9. PubMed ID: 6644602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of microsomal phenytoin metabolism by nafimidone and related imidazoles. Potency and structural considerations.
    Kapetanovic IM; Kupferberg HJ
    Drug Metab Dispos; 1985; 13(4):430-7. PubMed ID: 2863106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of alpidem and its metabolites in human plasma by high-performance liquid chromatography and fluorimetric detection.
    Ascalone V; Catalani P; Dal Bo' L; Deschamps N; Guinebault P
    J Chromatogr; 1987 Feb; 414(1):101-8. PubMed ID: 2883194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of nafimidone in the treatment of intractable partial seizures: report of a two-center pilot study.
    Treiman DM; Wilensky AJ; Ben-Menachem E; Ojemann L; Yerby M; Barber KO; McCormick KB; Cereghino JJ; White BG; Swisher K
    Epilepsia; 1985; 26(6):607-11. PubMed ID: 3935425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of naphazoline in rat plasma using column liquid chromatography with ultraviolet detection.
    Chabenat C; Boucly P
    Biomed Chromatogr; 1992; 6(5):241-3. PubMed ID: 1334441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of cibenzoline in plasma and urine by high-performance liquid chromatography.
    Hackman MR; Lee TL; Brooks MA
    J Chromatogr; 1983 Apr; 273(2):347-56. PubMed ID: 6863449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ionic liquids as mobile phase additives for feasible assay of naphazoline in pharmaceutical formulation by HPTLC-UV-densitometric method.
    Marszałł MP; Sroka WD; Balinowska A; Mieszkowski D; Koba M; Kaliszan R
    J Chromatogr Sci; 2013 Jul; 51(6):560-5. PubMed ID: 23076785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.